Best Researcher Award

Mansoure Mahdizadeh
National Research Institute for Science Policy, Iran

Mansoure Mahdizadeh is a researcher affiliated with the National Research Institute for Science Policy whose scholarly work addresses social policy, public affairs, sustainability, and interdisciplinary research. Her publications examine the influence of family social capital on social behavior and the interaction between the COVID-19 pandemic, carbon emissions, and energy consumption in Asian countries. Although her research portfolio is modest in size, it reflects engagement with policy-oriented topics that combine social science perspectives with contemporary global challenges. Citation metrics and continuing academic participation illustrate an emerging contribution to evidence-based research and public policy discussions.[1]

Abstract

This article presents a concise academic overview of Mansoure Mahdizadeh, emphasizing selected publications, research interests, scholarly impact, and relevance to research recognition. Her work demonstrates interdisciplinary analysis of social issues, environmental sustainability, and public policy while contributing to discussions supported by empirical research and collaborative investigation.[1]

Keywords

Social capital, social policy, sustainability, COVID-19, carbon emissions, energy consumption, STIRPAT model, public policy, interdisciplinary research, social development.

Introduction

Research addressing societal challenges increasingly benefits from interdisciplinary approaches that integrate social science, environmental studies, and policy analysis. Mansoure Mahdizadeh has participated in investigations exploring social behavior, sustainability, and energy-related issues. Her publications reflect interest in understanding complex relationships between public policy, environmental change, and community development through evidence-based research.[2]

Research Profile

Affiliated with the National Research Institute for Science Policy, Mansoure Mahdizadeh has contributed to studies involving sociology, sustainability, and policy research. Her academic profile includes an h-index of 2 and 14 citations, indicating the early stages of scholarly influence while demonstrating continued engagement with collaborative scientific publication and interdisciplinary inquiry.[1]

Research Contributions

Her research has examined the relationship between family social capital and social deviance in Iran while also investigating the combined effects of the COVID-19 pandemic, energy consumption, and carbon emissions across Asian countries. These studies contribute to policy discussions by linking social and environmental dimensions through quantitative analysis and interdisciplinary frameworks.[2]

Publications

• The Impact of Family Social Capital on Social Deviance in Iran. Social Problems of Iran, 2016.
• COVID-19, CO2 Emissions and Energy Consumption in Asian Countries: An Application of STIRPAT and Beck’s Theory of Risky Society. Petroleum Business Review, 2022.

Research Impact

The published studies demonstrate an interest in addressing contemporary policy issues with measurable social and environmental significance. Citation activity, collaborative authorship, and interdisciplinary methodology indicate that the research has contributed to ongoing academic discussions surrounding sustainable development, social policy, and evidence-informed decision-making.[1]

Award Suitability

Mansoure Mahdizadeh’s academic profile reflects interdisciplinary scholarship, collaboration, and a commitment to research addressing real-world societal challenges. Her work demonstrates qualities that are commonly considered in evaluations for academic recognition, including policy relevance, methodological rigor, and contributions to understanding social and environmental issues through scholarly investigation.[1]

Conclusion

The academic contributions of Mansoure Mahdizadeh highlight the value of interdisciplinary research in addressing complex societal and environmental questions. Through publications focused on social capital, sustainability, and policy analysis, her work supports informed discussion and provides a foundation for continued scholarly development within the international research community.

External Links

• ORCID Profile
• Google Scholar
• Award Website

References

1. Google Scholar. (n.d.). Mansoure Mahdizadeh – Research Profile.
   https://scholar.google.com/citations?user=IzutpS0AAAAJ&hl=en
2. Mahdizadeh, M., and collaborators. Selected publications on social capital, sustainability, and energy policy (2016–2022).
   https://orcid.org/0000-0001-8788-1282

Innovative Research Award

Max Lenz
Medical University of Vienna, Austria

Max Lenz is a researcher at the Medical University of Vienna whose work focuses on cardiovascular medicine, metabolic disorders, inflammatory diseases, and clinical biomarker research. His publications examine lipid metabolism, adipokines, obesity, and Fabry disease while contributing to a better understanding of cardiovascular risk assessment and patient management. Supported by peer-reviewed publications, an h-index of 14, and 466 citations, his research demonstrates consistent scholarly engagement and interdisciplinary collaboration across clinical cardiology and translational medicine.[1]

Abstract

This article summarizes the academic achievements of Max Lenz and outlines selected research contributions in cardiovascular medicine and metabolic science. His studies emphasize clinically relevant biomarkers, lipid metabolism, inflammatory mechanisms, and cardiovascular outcomes. The combination of collaborative publications, measurable citation impact, and translational research illustrates an active contribution to evidence-based medicine and cardiovascular research.[1]

Keywords

Cardiology, myocarditis, adipokines, lipid metabolism, Fabry disease, obesity, biomarkers, cardiovascular risk, intensive care medicine, translational research.

Introduction

Advances in cardiovascular medicine increasingly rely on integrating molecular biomarkers with clinical observations. Max Lenz has contributed to investigations exploring metabolic regulation, inflammatory pathways, and cardiovascular disease progression. His work reflects collaboration across multidisciplinary teams dedicated to improving diagnosis, prognosis, and patient care through scientifically validated clinical research.

Research Profile

Affiliated with the Medical University of Vienna, Max Lenz has established a publication record focused on cardiovascular metabolism and inflammatory disorders. His Scopus profile reports 466 citations and an h-index of 14, indicating growing scholarly influence. His publications appear in internationally recognized journals and involve collaborations with experts from multiple clinical specialties.[1]

Research Contributions

His research investigates adiponectin and leptin as metabolic biomarkers, evaluates lipid alterations in Fabry disease, and discusses obesity beyond conventional body-weight assessment. These studies contribute to understanding cardiometabolic risk, disease progression, and individualized treatment strategies, supporting evidence-based cardiovascular medicine and translational healthcare innovation.

Publications

• Longitudinal Adipokine and Lipid Profiles in Fabry Disease. DOI: 10.3390/jcm15062390
• Adiponectin, Leptin, and Lipid Profiles Characterise a Metabolic High-Risk Phenotype in ICU Patients. DOI: 10.1097/SHK.0000000000002814
• Beyond Obesity. DOI: 10.1093/ehjqcco/qcaf023

Research Impact

The research output of Max Lenz contributes to the expanding knowledge of cardiovascular metabolism and inflammatory disease. Citation metrics and publication quality indicate that his findings are referenced within ongoing scientific investigations, supporting further studies in cardiometabolic disorders and precision medicine.[1]

Award Suitability

Max Lenz demonstrates characteristics commonly associated with candidates for innovative research recognition, including interdisciplinary collaboration, publication in reputable journals, measurable citation performance, and clinically relevant scientific contributions. His work supports improved understanding of cardiovascular disease mechanisms while promoting translational approaches applicable to modern healthcare.[1]

Conclusion

The academic profile of Max Lenz reflects a commitment to cardiovascular and metabolic research through collaborative investigation and clinically meaningful publication. His work contributes to the understanding of biomarkers, obesity, inflammatory disease, and cardiovascular outcomes, providing a strong scholarly foundation that aligns with the objectives of international research recognition programs.

External Links

• ORCID Profile
• Scopus Author Profile
• Award Website

References

1. 1. Elsevier. (n.d.). Scopus author details: Max Lenz, Author ID 56589570700. Scopus.
      https://www.scopus.com/authid/detail.uri?authorId=56589570700

Best Researcher Award

Irene Fahim
Nile University, Egypt

Irene Fahim is an academic researcher affiliated with Nile University whose publications span human-computer interaction, advanced materials, renewable energy, and sustainable engineering. Her scholarly record reflects interdisciplinary collaboration supported by substantial citation performance and an established h-index. Through studies involving tactile perception, organic solar cells, and plastic waste conversion technologies, she has contributed to practical scientific knowledge with applications in engineering and technology development. These achievements provide a strong foundation for academic recognition while illustrating the value of collaborative and application-oriented research.[1]

Abstract

This article summarizes the academic profile of Irene Fahim and highlights representative research achievements that demonstrate interdisciplinary scientific engagement. Her publications combine engineering innovation with sustainability and technology-driven problem solving, producing measurable scholarly influence through citations and collaborative research activity.[1]

Keywords

Human-computer interaction, tactile memory, organic solar cells, polymers, renewable energy, plastic waste recycling, sustainable engineering, multidisciplinary research.

Introduction

Modern scientific research increasingly benefits from collaboration across multiple disciplines. Irene Fahim has participated in investigations ranging from interface technologies to sustainable materials and renewable energy systems. This diversity reflects an emphasis on practical innovation supported by peer-reviewed publication and measurable research visibility.

Research Profile

Her research profile demonstrates sustained participation in international scholarly publishing. Citation indicators, including 1,626 citations and an h-index of 22, suggest continuing academic influence. Collaboration with researchers from different institutions further illustrates engagement with multidisciplinary scientific communities and applied engineering research.[1]

Research Contributions

Representative contributions include evaluating directional tactile memory to improve reaction time, reviewing extraction methods for organic solar cell parameters, and investigating plastic waste conversion into usable fuel. Together these studies support advances in user-centered technologies, renewable energy, and sustainable resource utilization while addressing practical engineering challenges.

Publications

• The Effect of Directional Tactile Memory of the Back of the User on Reaction Time and Accuracy. DOI: 10.3390/electronics13132482
• Organic Solar Cells Parameters Extraction and Characterization Techniques. DOI: 10.3390/polym13193224
• Production of Fuel from Plastic Waste: A Feasible Business. DOI: 10.3390/polym13060915

Research Impact

The diversity of Irene Fahim’s publication portfolio demonstrates the capacity to address scientific questions with societal relevance. Citation performance reflects recognition by the research community, while publication in peer-reviewed journals supports the reliability and visibility of her scientific contributions.[1]

Award Suitability

Based on publication quality, interdisciplinary collaboration, citation metrics, and sustained scholarly productivity, Irene Fahim demonstrates characteristics commonly considered during evaluations for research excellence awards. Her work illustrates scientific relevance, innovation, and measurable academic influence across multiple engineering domains.[1]

Conclusion

Irene Fahim’s academic record highlights interdisciplinary scholarship, collaborative publication, and sustained citation impact. Her research contributes to technological innovation and sustainability while maintaining visibility within the international scientific community. These accomplishments provide a balanced foundation for recognition within academic award programs.

External Links

• ORCID Profile
• Scopus Author Profile
• Award Website

References

1. 1. Elsevier. (n.d.). Scopus author details: Irene Fahim, Author ID 56572668600. Scopus.
      https://www.scopus.com/authid/detail.uri?authorId=56572668600

Best Researcher Award

Antonio Cannatà
King’s College London, United Kingdom

Antonio Cannatà is a cardiovascular researcher affiliated with King’s College London whose scholarly work focuses on heart failure, myocarditis, cardio-kidney-metabolic disorders, and evidence-based cardiovascular medicine. His peer-reviewed publications demonstrate continued contributions to understanding disease progression, clinical outcomes, and guideline development for patients with complex cardiovascular conditions. Through multidisciplinary collaborations and international research initiatives, his publications support improved diagnosis, risk assessment, and therapeutic decision-making in modern cardiology.[1]

Abstract

Antonio Cannatà’s research focuses on cardiovascular medicine, particularly heart failure, myocarditis, and cardio-kidney-metabolic disorders. His publications integrate clinical investigation, multicentre collaboration, and translational research to improve understanding of disease mechanisms, prognosis, and patient management. His studies support international cardiovascular research through evidence on myocarditis, sudden cardiac death, and heart failure guidelines.

Keywords

Cardiology, Heart Failure, Myocarditis, Cardiovascular Medicine, Clinical Research, Cardio-Kidney-Metabolic Disease, Evidence-Based Medicine, Medical Guidelines, Translational Medicine, Cardiovascular Outcomes.

Introduction

Cardiovascular diseases remain a leading global health challenge, requiring advances in diagnosis, prevention, and treatment. Antonio Cannatà contributes through collaborative research on myocarditis, heart failure, and complex cardiovascular disorders. His publications translate clinical evidence into improved patient care while supporting guideline development and fostering international scientific collaboration.[2]

Research Profile

Based at King’s College London, Antonio Cannatà has established a multidisciplinary research profile in cardiovascular medicine. His Scopus metrics, including an h-index of 32 and over 3,900 citations, reflect sustained scholarly impact. His work spans observational studies, clinical investigations, and consensus documents addressing disease progression, risk stratification, and evidence-based cardiovascular care.[1]

Research Contributions

• Advanced understanding of recurrent myocarditis through multicentre international clinical investigations.
• Contributed to expert consensus recommendations supporting heart failure management in resource-limited healthcare environments.
• Investigated sudden death risk in cardio-kidney-metabolic patients using contemporary cardiovascular evidence.
• Supported collaborative cardiovascular research integrating clinical outcomes with guideline development.

Publications

• Sudden Death in Cardio-Kidney-Metabolic Patients. JACC (2026).
  DOI: 10.1016/j.jacc.2026.05.031
• Bridging the Gap: Adapting Heart Failure Guidelines for Resource-Limited Settings. European Journal of Heart Failure (2026). DOI: 10.1093/ejhf/xuag142
• Insights Into the Natural History of Recurrent Myocarditis. Journal of the American Heart Association (2026). DOI: 10.1161/JAHA.125.046767

Research Impact

Antonio Cannatà’s research advances cardiovascular medicine through clinical studies, evidence synthesis, and guideline development. His publications on myocarditis, heart failure, and cardio-kidney-metabolic disorders enhance understanding of disease management and patient outcomes. His h-index, citation impact, and multidisciplinary collaborations demonstrate sustained scholarly influence and clinical relevance. [1]

Award Suitability

Antonio Cannatà demonstrates research excellence through sustained contributions to cardiovascular medicine. His publications, citation impact, and multinational collaborations have advanced knowledge in myocarditis, heart failure, cardiovascular risk, and clinical guidelines. His rigorous, collaborative scholarship and clinically relevant research align with the objectives of the Best Researcher Award. [2]

Conclusion

Antonio Cannatà has established a distinguished academic profile through sustained contributions to cardiovascular medicine. His research on myocarditis, heart failure, and cardio-kidney-metabolic disease advances patient care and scientific understanding. His publication record, citation impact, and collaborative research demonstrate lasting contributions to cardiovascular science, interdisciplinary innovation, and evidence-based healthcare.

External Links

• ORCID Profile
• Scopus Author Profile
• Featured Publication DOI
• Award Website

References

1. Elsevier. (n.d.). Scopus author details: Antonio Cannatà, Author ID 56950331100. Scopus.
   https://www.scopus.com/authid/detail.uri?authorId=56950331100
2. Cannatà A., et al. (2026). Sudden Death in Cardio-Kidney-Metabolic Patients. JACC.
   DOI: https://doi.org/10.1016/j.jacc.2026.05.031
3. Abdin A., Aktaa S., Cannatà A., et al. (2026). Bridging the Gap: Adapting Heart Failure Guidelines for Resource-Limited Settings. European Journal of Heart Failure.
   DOI: https://doi.org/10.1093/ejhf/xuag142
4. Baggio C., Cannatà A., et al. (2026). Insights Into the Natural History of Recurrent Myocarditis, A Multicenter International Study. Journal of the American Heart Association.
   DOI: https://doi.org/10.1161/JAHA.125.046767

Best Researcher Award

Rebecca Neiberg
Wake Forest University, United States

Rebecca Neiberg is a researcher at Wake Forest University whose scholarly work has contributed significantly to cardiovascular health, aging research, obesity, diabetes, and clinical biostatistics. Her publications emphasize evidence-based approaches for evaluating lifestyle interventions, long-term health outcomes, and chronic disease management. Through multidisciplinary collaborations, her research supports improvements in preventive medicine, healthy aging, and cardiovascular risk assessment while providing statistically rigorous analyses for large clinical studies.[1]

Abstract

Rebecca Neiberg’s research portfolio encompasses cardiovascular medicine, obesity, diabetes, gerontology, and statistical methodology. Her collaborative investigations evaluate dietary interventions, physical function, disability prevention, and metabolic outcomes in aging populations. These contributions provide valuable evidence supporting clinical decision-making and public health strategies for chronic disease prevention.[1]

Keywords

Cardiovascular Research, Healthy Aging, Diabetes, Obesity, Clinical Trials, Biostatistics, Lifestyle Intervention, Gerontology, Metabolic Health, Preventive Medicine.

Introduction

The increasing prevalence of cardiovascular disease and metabolic disorders highlights the importance of high-quality clinical research. Rebecca Neiberg has participated in large collaborative studies investigating lifestyle modification, caloric restriction, weight management, and long-term functional health among older adults. Her analytical expertise contributes to reliable interpretation of clinical outcomes.[2]

Research Profile

According to the supplied academic profile, Rebecca Neiberg has accumulated 4,364 citations with an h-index of 35. Her research emphasizes longitudinal clinical studies, advanced statistical analyses, cardiovascular outcomes, diabetes management, obesity interventions, and aging-related health research through collaborative, multidisciplinary investigations.[1]

Research Contributions

Recent publications examine caloric restriction with time-restricted eating in older adults, long-term disability outcomes following the Look AHEAD clinical trial, and relationships between adiposity reduction, HbA1c improvement, and insulin use. These studies enhance understanding of cardiovascular risk reduction and healthy aging through evidence-based interventions.[2]

Publications

• Caloric restriction and time-restricted eating in older adults with overweight or obesity (2026).
• Late-life disability following the Action for Health in Diabetes (Look AHEAD) trial (2026).
• Associations between decreases in adiposity and reductions in HbA1c and insulin use in the Look AHEAD cohort (2025).

Research Impact

The combination of extensive citation impact, sustained publication record, and participation in influential multicenter clinical studies demonstrates meaningful contributions to cardiovascular and aging research. Her work supports clinicians, researchers, and healthcare policymakers seeking evidence for effective chronic disease management.[1]

Award Suitability

Rebecca Neiberg’s sustained scholarly productivity, high citation record, and collaborative leadership in cardiovascular, obesity, and aging research align well with the objectives of the International Research Awards on Cardiology & Cardiovascular Medicine, recognizing impactful scientific achievement and excellence in translational health research.[1]

Conclusion

Rebecca Neiberg has established a distinguished research profile through rigorous statistical analysis, collaborative clinical investigation, and evidence-based studies addressing cardiovascular health and healthy aging. Her contributions continue to strengthen scientific understanding of lifestyle interventions and long-term health outcomes in aging populations.[2]

External Links

• ORCID Profile
• Scopus Author Profile
• Representative DOI
• Award Website

References

1. Elsevier. (n.d.). Scopus author details: Rebecca Neiberg, Author ID 15842082400. Scopus.
   https://www.scopus.com/authid/detail.uri?authorId=15842082400
2. Houston DK, Fanning J, Nicklas BJ, et al. Caloric restriction and time-restricted eating in older adults with overweight or obesity. The Journals of Gerontology: Series A (2026).
   DOI: https://doi.org/10.1093/gerona/glag061
3. Semelka CT, Neiberg RH, Haynie HD, et al. Late-life disability following the Action for Health in Diabetes (Look AHEAD) trial. The Journals of Gerontology: Series A (2026).
   DOI: https://doi.org/10.1093/gerona/glaf245

Research Excellence Award

Murimisi Mukansi
University of The Witwatersrand, South Africa

Murimisi Mukansi is a researcher at the University of The Witwatersrand whose academic interests encompass cardiovascular medicine, infectious diseases, pulmonary disorders, and biomarker-based clinical investigations. His published work demonstrates an evidence-based approach to understanding disease mechanisms and improving patient management through translational medical research. With an established Scopus profile, consistent citation record, and growing international visibility, his contributions support advances in cardiovascular science and clinical medicine while promoting interdisciplinary collaboration between laboratory investigation and patient-centered healthcare.[1]

Abstract

The research activities of Murimisi Mukansi focus on cardiovascular complications associated with infectious diseases, particularly pneumonia and COVID-19. His investigations evaluate clinical manifestations, cardiac biomarker responses, and disease severity to strengthen diagnostic accuracy and improve patient outcomes. The published findings contribute to evidence-based cardiovascular medicine and interdisciplinary clinical research.[2]

Keywords

Cardiovascular Medicine, COVID-19, Community-Acquired Pneumonia, Cardiac Biomarkers, Clinical Research, Translational Medicine, Infectious Diseases, Medical Diagnostics.

Introduction

Modern cardiovascular medicine increasingly recognizes the influence of infectious diseases on cardiac health. Investigating biomarker profiles, inflammatory responses, and clinical outcomes provides valuable evidence for optimizing diagnosis and treatment. Research in this area supports improved management of patients presenting with complex cardiopulmonary conditions.[2]

Research Profile

Murimisi Mukansi has established an academic profile through publications in peer-reviewed medical journals, supported by 170 citations and an h-index of 5. His work demonstrates expertise in cardiovascular investigations, infectious disease pathology, biomarker evaluation, and collaborative clinical research that addresses contemporary healthcare challenges.[1]

Research Contributions

His recent publication examining clinical characteristics and cardiac biomarker elevation among patients with community-acquired pneumonia and COVID-19 pneumonia provides comparative evidence supporting cardiovascular risk assessment in infectious diseases. Such studies contribute to improved clinical interpretation, patient stratification, and therapeutic decision-making.[2]

Publications

• Distinct Patterns of Clinical Features and Cardiac Biomarker Elevation in Community-Acquired Pneumonia and COVID-19 Pneumonia. Pathogens, 2026.

Research Impact

The research contributes to a broader understanding of cardiovascular complications associated with respiratory infections. By integrating biomarker analysis with clinical observations, the findings support precision medicine, improved patient monitoring, and evidence-informed healthcare strategies for complex infectious diseases.[2]

Award Suitability

Murimisi Mukansi demonstrates qualities consistent with recognition through the International Research Awards on Cardiology & Cardiovascular Medicine. His scholarly contributions, publication quality, interdisciplinary collaborations, and focus on clinically relevant cardiovascular research illustrate scientific excellence and meaningful impact within contemporary medical research.

Conclusion

Murimisi Mukansi has developed a research portfolio centered on cardiovascular complications arising from infectious diseases. His work strengthens understanding of disease mechanisms, supports improved diagnostic practice, and contributes valuable evidence for clinicians and researchers seeking to enhance patient care through translational cardiovascular science.

External Links

• ORCID Profile
• Scopus Author Profile
• DOI Link
• Award Website

References

1. Elsevier. (n.d.). Scopus author details: Murimisi Mukansi, Author ID 56659430900. Scopus.
   https://www.scopus.com/authid/detail.uri?authorId=56659430900
2. Mukansi, M., Steel, H. C., Rossouw, T. M., et al. (2026). Distinct Patterns of Clinical Features and Cardiac Biomarker Elevation in Community-Acquired Pneumonia and COVID-19 Pneumonia. Pathogens.
   DOI: https://doi.org/10.3390/pathogens15070676